Partnership opportunities

Our Business Development team are recognised for their experience in intellectual property management and commercialisation.

With our researchers and their discoveries, the team have a strong pipeline of translatable biomedical discoveries. The focus is on the translation of research to deliver health benefits to the community, increasingly this requires commercial partnerships to progress discoveries through to the marketplace. Below are some of our research and technology areas of expertise. Contact us if you are interested in these, or if you have specific area you would like to pursue.

Central Nervous System

SRY inhibition to treat Parkinson’s Disease in males
Treatment for White Matter Impairment in Newborns

Gene Therapy

RNA interference with Potent Immune System Activation
SRY inhibition to treat Parkinson’s Disease in males

Infectious Diseases

TLR7/8 Antagonists: Anti-bacterial and Anti-inflammatory Agents

Inflammation

Exosome Therapy – a cell-free approach to regenerative medicine
RNA interference with Potent Immune System Activation
TLR7/8 Antagonists: Anti-bacterial and Anti-inflammatory Agents

Oncology

Small molecule inhibitors of liver Receptor Homolgo-1 (LRH-1)

Paediatrics

Treatment for White Matter Impairment in Newborns

Reproductive Health

Treating pelvic organ prolapse. A tissue engineering approach using novel designed scaffolds embedded with autologous endometrial mesenchymal stem cells.

Regenerative Medicine

Exosome Therapy – a cell-free approach to regenerative medicine

Women’s Health

Treating pelvic organ prolapse. A tissue engineering approach using novel designed scaffolds embedded with autologous endometrial mesenchymal stem cells.